<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_SUSTC-Shenzhen_Project_gRNA-binding-target-sequence_Plasmids_Design_and_Construction"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence Plasmids Design and Construction</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><P><TITLE>Team SUSTC-Shenzhen</TITLE></P><DIV class="container"><NAV class="navbar navbar-default navbar-fixed-top" role="navigation" id="index-nav-main"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav"><LI><A href="/Team:SUSTC-Shenzhen">Home</A></LI><LI><A href="/Team:SUSTC-Shenzhen/Project">Project</A></LI><LI><A href="/Team:SUSTC-Shenzhen/Notebook">Notebook</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown">More</A></LI><LI><A href="/Team:SUSTC-Shenzhen/JudgingForm">Judging Form</A></LI><LI><A href="/Team:SUSTC-Shenzhen/Attributions">Attributions</A></LI></UL><LI><A href="https://igem.org/Team.cgi?id=1431">Team Profile</A></LI><UL class="nav navbar-nav navbar-right"><LI><FORM action="/Special:Search" id="searchform" class="navbar-form" role="search"><BUTTON type="submit" name="go" class="btn btn-default" id="mw-searchButton" value="Go" title="Search the pages for this text">Search</BUTTON></FORM></LI><LI><A id="nav-login-status">Log in</A></LI></UL></DIV></NAV></DIV><DIV class="bs-docs-header"><DIV class="container"><H1>

gRNA-binding-target-sequence Plasmids Design and Construction

        </H1></DIV></DIV><DIV id="main-content" class="container"><DIV class="col-md-3" id="document-sidebar"><TABLE id="toc" class="toc"><TBODY><TR><TD><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Abstract"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Abstract</SPAN></A></LI><LI class="toclevel-1 tocsection-2"><A href="#Part_I_Plasmid_construction_Design:_Why_do_we_construct_them.3F"><SPAN class="tocnumber">2</SPAN><SPAN class="toctext">Part I Plasmid construction Design: Why do we construct them?</SPAN></A></LI><LI class="toclevel-2 tocsection-3"><A href="#Why_do_we_design_plasmids_that_put_target-sequence_between_promoter_and_EGFP.3F"><SPAN class="tocnumber">2.1</SPAN><SPAN class="toctext">Why do we design plasmids that  put target-sequence between promoter and EGFP?</SPAN></A></LI><LI class="toclevel-2 tocsection-4"><A href="#Why_dose_each_of_our_plasmids_only_carries_sections_of_genome.3F"><SPAN class="tocnumber">2.2</SPAN><SPAN class="toctext">Why dose each of our plasmids only carries sections of genome?</SPAN></A></LI></UL><LI class="toclevel-1 tocsection-5"><A href="#Part_II_Method:_How_do_we_construct_them.3F"><SPAN class="tocnumber">3</SPAN><SPAN class="toctext">Part II Method: How do we construct them?</SPAN></A></LI><LI class="toclevel-1 tocsection-6"><A href="#Remark"><SPAN class="tocnumber">4</SPAN><SPAN class="toctext">Remark</SPAN></A></LI></TD></TR></TBODY></TABLE></DIV><DIV class="col-md-9" id="document-body"><P>In this part, we have totally constructed <B>3 plasmids</B>, to binding the gRNA sequences in human cells nucleus.
</P><H2><SPAN class="mw-headline" id="Abstract"><B>Abstract</B></SPAN></H2><P>There are <B>three</B> target-sequence related plasmids. Each one corresponding a unique gRNA. </P><P><B>This three </B> plasmid carry the <B>Target-sequence</B> aim to <B>check</B> if <B>the CRISPR-Cas9 system</B> we create in human cell can work well, which might be the foundation for the further experiments. <B>. </B></P><P>However, although each one with different target-sequence, they still have plenty of components in common. You can see, all of them carry <B>at least one section of target-sequences</B>, and target-sequence for HBV1-HBV2 have two sections of target-sequence.This is because this part plays an important role in <B>efficiency test</B>, both for target-sequence binding gRNA and cut-off ability of CRISPR-Cas9. </P><P>Following are these three plasmids:
</P><H2><SPAN class="mw-headline" id="Part_I_Plasmid_construction_Design:_Why_do_we_construct_them.3F"><B>Part I Plasmid construction Design:</B> Why do we construct them?</SPAN></H2><H3><SPAN class="mw-headline" id="Why_do_we_design_plasmids_that_put_target-sequence_between_promoter_and_EGFP.3F"><B>Why do we design plasmids that <FONT color="blue"> put target-sequence between promoter and EGFP?</FONT></B></SPAN></H3><P>As we all know,the double strands break of target-sequence is hard to observe in the human cell,it have no function for the normal activity of the cell,so we use the alternative solution.We insert the gRNA binding sequence between the promoter and reporter, transform the expression of DSB of binding sequence to the change of reporter. The whole target-sequence have a gRNA binding sequence in the middle and have more original sequence in two sides to return the natural state of HIV genome. </P><P><I><B>By this way, we can observe the DSB happen or not by the expression of EGFP. </B></I></P><H3><SPAN class="mw-headline" id="Why_dose_each_of_our_plasmids_only_carries_sections_of_genome.3F"><B>Why dose each of our plasmids only carries<FONT color="blue"> sections of genome?</FONT></B></SPAN></H3><P>For safety,we can't use whole HIV or HBV genome in the lab, and actually the double strands break of genome is not vivid for quantitative.</P><P><B>In the alternative ,the fluorescence will directly link to the efficiency of double strands break,that's what we need.</B></P><H2><SPAN class="mw-headline" id="Part_II_Method:_How_do_we_construct_them.3F"><B>Part II Method:</B> How do we construct them?</SPAN></H2><P><B>Preparation of plasmid backbone:</B>
All plasmids we constructed are based on the plasmid pBX-083PB5-HS4-EF1A-EGFPnuc-2A-Bla-LoxN-BGpA-HS4-PB3 (7896bp, HongKong) We use NcoI, BspEI to do enzyme digestion of plasmid pBX-083PB5-HS4-EF1A-EGFPnuc-2A-Bla-LoxN-BGpA-HS4-PB3, removing the entire EGFP sequence and collect the remaining 7179bp DNA fragment as ligation vector for the following experiments.</P><P><B>PCR for target-sequence from plasmid pBX-083PB5-HS4-EF1A-EGFPnuc-2A-Bla-LoxN-BGpA-HS4-PB3 (7896, HongKong):</B>
First,we acquire our target-sequence locate between the promoter and EGFP by add target-sequence on primer.Second,we must mutate extra NcoI and BspEI enzyme site on the PCR product. <U>With primers A, we achieve:</U>
Get the target-sequence with EGFP, also with NcoII and BspEI enzyme sites added on each end.
Primers target-sequence for HIV:
Forward (5’-3’): CATGCCATGGGATCAAAATCTCTAGCAGTGGCGCCCGAACAGGGACccttggtgagcaagggcgagg
Reverse (5’-3’): TACCTCCGGAGGGtccggtcttgtacagctcgtc
Primers target-sequence for HBV2:
Forward (5’-3’): CATGCCATGGGATCTCTCCTCTGCCGATCCATACTGCGGAACTCCTccttggtgagcaagggcgagg
Reverse (5’-3’): TACCTCCGGAGGGtccggtcttgtacagctcgtc
Primers target-sequence for HBV1-2:
Forward (5’-3’): CATGCCATGGGATCCCTAGGACCCCTGCTCGTGTTACAGGCGGccttggtgagcaagggcgagg
Reverse (5’-3’): CATGCCATGGGATCCCTAGGACCCCTGCTCGTGTTACAGGCGGccttggtgagcaagggcgagg</P><P><B>Construction of gRNA carried plasmids by Restriction enzyme digestion &amp; Ligation:</B>
Do enzyme digestion (with NcoI &amp; BspEI) of PCR product.
Ligation for backbone and target-sequence. Thus, we get the target-sequence with EGFP plasmid.</P><P>
Thus, we get the target-sequence carried plasmid:
TargetsequenceforHIV1-pBX-083PB5-HS4-EF1A-EGFPnuc-2A-Bla-LoxN-BGpA-HS4-PB3
TargetsequenceforHBV2-pBX-083PB5-HS4-EF1A-EGFPnuc-2A-Bla-LoxN-BGpA-HS4-PB3
TargetsequenceforHBV1-2-pBX-083PB5-HS4-EF1A-EGFPnuc-2A-Bla-LoxN-BGpA-HS4-PB3</P><H2><SPAN class="mw-headline" id="Remark"><B>Remark</B></SPAN></H2><P>The results of efficiency test for target-sequence binding gRNA transportation and CRISPR-Cas9 cut-off ability can be found in A-B toxin Part &amp; Cell Culture Part.
</P><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction">http://2014.igem.org/Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:SUSTC-Shenzhen/Project/gRNA-binding-target-sequence_Plasmids_Design_and_Construction&amp;oldid=396054" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></DIV></DIV></BODY></HTML>